Iguana Healthcare Management LLC lessened its position in shares of K2M Group Holdings Inc (NASDAQ:KTWO) by 12.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 175,000 shares of the medical device company’s stock after selling 25,000 shares during the quarter. K2M Group comprises 2.1% of Iguana Healthcare Management LLC’s portfolio, making the stock its 14th biggest holding. Iguana Healthcare Management LLC owned approximately 0.40% of K2M Group worth $3,150,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in KTWO. Cubist Systematic Strategies LLC boosted its holdings in shares of K2M Group by 7,765.0% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 4,719 shares of the medical device company’s stock worth $100,000 after purchasing an additional 4,659 shares during the period. Teacher Retirement System of Texas purchased a new position in shares of K2M Group in the 4th quarter worth approximately $213,000. Trexquant Investment LP purchased a new position in shares of K2M Group in the 3rd quarter worth approximately $223,000. Quantbot Technologies LP boosted its holdings in shares of K2M Group by 275.9% in the 3rd quarter. Quantbot Technologies LP now owns 10,593 shares of the medical device company’s stock worth $224,000 after purchasing an additional 7,775 shares during the period. Finally, Oppenheimer Asset Management Inc. purchased a new position in shares of K2M Group in the 3rd quarter worth approximately $347,000. Institutional investors and hedge funds own 99.31% of the company’s stock.
Shares of K2M Group stock opened at $20.92 on Monday. K2M Group Holdings Inc has a one year low of $16.44 and a one year high of $25.99. The company has a current ratio of 2.84, a quick ratio of 1.52 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $907.67, a P/E ratio of -24.05 and a beta of 1.42.
KTWO has been the subject of a number of recent research reports. Zacks Investment Research cut K2M Group from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. BidaskClub cut K2M Group from a “buy” rating to a “hold” rating in a report on Wednesday, December 6th. Wells Fargo cut K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 target price for the company. in a report on Monday, December 4th. Needham & Company LLC lowered K2M Group from a “strong-buy” rating to a “buy” rating and decreased their price target for the stock from $26.00 to $20.00 in a research note on Friday, December 8th. Finally, Barclays reissued a “buy” rating and set a $25.00 price target on shares of K2M Group in a research note on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have given a buy rating to the company. K2M Group currently has a consensus rating of “Buy” and a consensus price target of $24.50.
K2M Group Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Want to see what other hedge funds are holding KTWO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for K2M Group Holdings Inc (NASDAQ:KTWO).
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.